You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nanostring

Showing 1 - 25 of 159
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HostDx Sepsis™ on NanoString;Prospective Observational

Completed
  • Sepsis
  • HostDx Sepsis
  • Gainesville, Florida
    University of Florida College of Medicine
Dec 7, 2021

Host Blood RNA Signatures for Diagnosis of TB (RADIANT)

Recruiting
  • Tuberculosis
  • NanoString nCounter assay
  • Cape Town, Western Cape, South Africa
  • +1 more
Sep 12, 2022

Prosigna Assay on Neoadjuvant Clinical Decision-making in

Recruiting
  • Breast Cancer
  • Prosigna PAM-50 assay
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Apr 5, 2022

Neoadjuvant Operable Breast Cancer Trial in Paris, Villejuif (Fluorouracile, Epirubicin, Cyclophosphamide)

Completed
  • Neoadjuvant Operable Breast Cancer
  • Paris, France
  • +1 more
Mar 14, 2022

Melanoma Trial in United States (Ensartinib, ALKATI by Customized Nanostring Assay)

Active, not recruiting
  • Melanoma
  • Middletown, New Jersey
  • +3 more
Jan 25, 2022

Breast Cancer Radiation Trial in United States (Prosigna)

Active, not recruiting
  • Breast Cancer Radiation
  • Prosigna
  • Baltimore, Maryland
  • +5 more
Jul 7, 2022

Profile of Sunitinib Response in Metastatic Clear Cell Renal

Completed
  • Kidney Cancer
  • +2 more
  • Gene expression test using nanostring technology.
  • Barretos, Sao Paulo, Brazil
    Andre Octavio Nicolau Sanches
May 31, 2020

Breast Cancer Female, Hormone Receptor Positive Tumor Trial in Vancouver (Tamoxifen Citrate)

Recruiting
  • Breast Cancer Female
  • Hormone Receptor Positive Tumor
  • Tamoxifen Citrate
  • Vancouver, British Columbia, Canada
    BC Cancer
Dec 7, 2020

Immune Response in Desensitized Patients

Not yet recruiting
  • Kidney Transplant Rejection
  • Desensitization
  • (no location specified)
Mar 26, 2023

Bordetella Pertussis, Whooping Cough Trial in France (Nasopharyngeal swab, Blood samples)

Not yet recruiting
  • Bordetella Pertussis, Whooping Cough
  • Nasopharyngeal swab
  • Blood samples
  • Bordeaux, France
  • +13 more
Jun 1, 2023

Asthma; Eosinophilic Trial (Mepolizumab 100 MG)

Recruiting
  • Asthma
  • Eosinophilic Asthma
  • Mepolizumab 100 MG
  • Ferrol, A Coruña, Spain
  • +4 more
Sep 5, 2022

CINSARC Genomic Signature as Predictor of Resectability of

Completed
  • Ovarian Adenocarcinoma
  • CINSARC signature
  • Toulouse, France
    Institut Claudius Regaud Institut Universitaire du cancer Toulou
Dec 22, 2022

Umbrella Trial in Relapsed Small Cell Lung Cancer Patients

Recruiting
  • Small Cell Lung Cancers
  • No treatment is included in this protocol.
  • Seoul, Korea, Republic of
    Se-Hoon Lee
Aug 26, 2021

Multiple Sclerosis, Relapsing-Remitting Trial in Paris (50 ml blodd sampling)

Not yet recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • 50 ml blodd sampling
  • Paris, France
    Hôpital La Pitié - Salpêtrière
Aug 16, 2022

Stomach Tumors Trial in Seoul (Molecular profiling)

Completed
  • Stomach Neoplasms
  • Molecular profiling
  • Seoul, Korea, Republic of
  • +1 more
Jun 13, 2022

Healthy Subjects, Cancer, Tumors Trial in Leiden (Fasting Mimicking Diet)

Completed
  • Healthy Subjects
  • +2 more
  • Fasting Mimicking Diet
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Jul 25, 2022

Antibody Mediated Processes After Kidney Transplantation

Recruiting
  • Kidney Transplant Failure and Rejection
  • AlloSure ddcfDNA assay
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin - Madison
Aug 16, 2022

Early On-treatment Transcriptional Profiling as Predictor of

Recruiting
  • HER2-positive Breast Cancer
  • +2 more
  • Trastuzumab (neoadjuvant)
  • +2 more
  • Hospitalet de Llobregat, Barcelona, Spain
    Institut Català d'Oncologia l'Hospitalet
Jun 12, 2023

Including miRNA-based Tumor Signatures in Diffuse Large B Cell

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • no intervention (observational study)
  • Napoli, Italy
  • +2 more
Feb 17, 2023

Triple Negative Breast Cancer Trial in Shanghai (Eribulin, Tislelizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 29, 2021

Iron-deficiency, Colorectal Cancer Trial in Køge, Slagelse, Randers (Iron(III)isomaltoside, Placebo)

Not yet recruiting
  • Iron-deficiency
  • Colorectal Cancer
  • Køge, Danmark, Denmark
  • +2 more
Feb 14, 2022

Head and Neck Squamous Cell Carcinoma Trial in Toronto (MET-4)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Nickel; Eczema, Nickel Sensitivity, Allergy Trial in Hellerup (Nickel sulfate hexahydrate)

Active, not recruiting
  • Nickel; Eczema
  • +3 more
  • Nickel sulfate hexahydrate
  • Hellerup, Danmark, Denmark
    National Allergy Research Center
Apr 5, 2022

Genetic Architecture of Neutrophil-Mediated Inflammatory Skin

Not yet recruiting
  • Neutrophil-mediated Inflammatory Dermatoses
  • Inflammatory Dermatoses
  • Analysis of samples
  • Basel, Switzerland
    University Hospital Basel, Clinic of Dermatology
Feb 20, 2023

HNSCC, Head and Neck Tumors Trial in Seoul (BYL719, Poziotinib, Nintedanib)

Completed
  • HNSCC
  • Head and Neck Neoplasms
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 27, 2022